SCHEMBL8919072

SCHEMBL8919072

CCCCCCCCOc1ncc(-c2ccc(O)cc2)cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR5A1 Q13285 1/20 0.57
LTA4H P09960 2/20 0.50
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
MAPT P10636 1/20 0.49
STAT3 P40763 1/20 0.49
ATM Q13315 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
RARB P10826 3/20 0.44
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.43
ESR1 P03372 2/20 0.43
ADRA2A P08913 2/20 0.43
ADORA3 P0DMS8 2/20 0.43
TACR2 P21452 2/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
SLC6A3 Q01959 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8034268 1.00 NR5A1 (0.57) NR5A1LTA4HNPC1RAB9AMAPT
SCHEMBL9510068 1.00 NR5A1 (0.57) NR5A1LTA4HNPC1RAB9AMAPT
SCHEMBL9506148 0.85 CYP2D6 (0.57) NR5A1LTA4HNPC1RAB9ASMN1; SMN2
SCHEMBL9506174 0.85 CYP2D6 (0.57) NR5A1LTA4HNPC1RAB9ASMN1; SMN2
SCHEMBL7883759 0.83 NR5A1 (0.56) NR5A1LTA4HNPC1RAB9AMAPT
SCHEMBL9228047 0.82 NR5A1 (0.69) NR5A1LTA4HNPC1RAB9AMAPT
SCHEMBL10574379 0.82 NR5A1 (0.69) NR5A1LTA4HNPC1RAB9AMAPT
SCHEMBL6255603 0.82 NR5A1 (0.69) NR5A1LTA4HNPC1RAB9AMAPT
SCHEMBL9343934 0.82 NR5A1 (0.69) NR5A1LTA4HNPC1RAB9AMAPT
SCHEMBL10337755 0.82 NR5A1 (0.69) NR5A1LTA4HNPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5651918-A Optically active 1,3-dioxolane derivatives carrying a mesogenic radical in the 4-position, a process for their preparation and their use as doping agents in liquid-crystal mixtures HOECHST AKTIENGESELLSCHAFT (DE) 1997-07-29 US disclosed
US-5384070-A Use of optically active tetrahydrofuran-2-carboxylic acid esters as dopants in liquid-crystal mixtures, liquid-crystal mixtures containing same and novel optically active tetrahydrofuran-2-carboxylic acid esters HOECHST AKTIENGESELLSCHAFT (DE) 1995-01-24 US disclosed
US-5380460-A Ferroelectric liquid crystal compounds containing chiral haloalkoxy tail units and compositions containing them DISPLAYTECH, INC. (US) 1995-01-10 US disclosed
EP-0351746-B1 Optically active 1,3-dioxolane derivatives containing a mesogene group in position 4, method for their preparation and their use as doping agents in liquid-crystal mixtures HOECHST AG (DE) 1993-12-29 EP disclosed
WO-1993020068-A1 CHIRAL OXIRANE DERIVATIVES AND THEIR USE AS DOPING AGENTS IN LIQUID CRYSTAL MIXTURES HOECHST AKTIENGESELLSCHAFT (DE) 1993-10-14 WO disclosed
WO-1993006192-A1 FERROELECTRIC LIQUID CRYSTAL COMPOUNDS CONTAINING CHIRAL HALOALKOXY TAIL UNITS AND COMPOSITIONS CONTAINING THEM DISPLAYTECH, INCORPORATED (US) 1993-04-01 WO disclosed
EP-0355561-B1 USE OF OPTICALLY ACTIVE TETRAHYDROFURAN-2-CARBOXYLIC-ACID ESTERS IN DOPING LIQUID-CRYSTAL MIXTURES, LIQUID-CRYSTAL MIXTURES CONTAINING THEM, AND OPTICALLY ACTIVE TETRAHYDROFURAN-2-CARBOXYLIC-ACID ESTERS HOECHST AKTIENGESELLSCHAFT (DE) 1992-11-19 EP disclosed
EP-0438811-A2 Esters of 3-halogeno- or 3-cyano-substituted 2-methylalkanecarboxylic acids and their use as doping agents in liquid-crystalline compositions HOECHST AKTIENGESELLSCHAFT (DE) 1991-07-31 EP disclosed
EP-0355561-A1 Use of optically active tetrahydrofuran-2-carboxylic-acid esters in doping liquid-crystal mixtures, liquid-crystal mixtures containing them, and optically active tetrahydrofuran-2-carboxylic-acid esters HOECHST AKTIENGESELLSCHAFT (DE) 1990-02-28 EP disclosed
EP-0351746-A1 Optically active 1,3-dioxolane derivatives containing a mesogene group in position 4, method for their preparation and their use as doping agents in liquid-crystal mixtures HOECHST AKTIENGESELLSCHAFT (DE) 1990-01-24 EP disclosed